These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 26453678

  • 1. What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
    Feinstein A, Banwell E, Pavisian B.
    Mult Scler; 2015 Dec; 21(14):1755-60. PubMed ID: 26453678
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
    Romero K, Pavisian B, Staines WR, Feinstein A.
    Neuroimage Clin; 2015 Dec; 8():140-7. PubMed ID: 26106538
    [Abstract] [Full Text] [Related]

  • 3. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Feinstein A, Meza C, Stefan C, Staines RW.
    Brain; 2019 Sep 01; 142(9):2800-2812. PubMed ID: 31363742
    [Abstract] [Full Text] [Related]

  • 4. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O, Feinstein A.
    Neurology; 2008 Jul 15; 71(3):164-9. PubMed ID: 18272863
    [Abstract] [Full Text] [Related]

  • 5. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.
    Mult Scler Relat Disord; 2019 Jan 15; 27():383-390. PubMed ID: 30502644
    [Abstract] [Full Text] [Related]

  • 6. Effects of cannabis on cognitive function in patients with multiple sclerosis.
    Honarmand K, Tierney MC, O'Connor P, Feinstein A.
    Neurology; 2011 Mar 29; 76(13):1153-60. PubMed ID: 21444900
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Messinis L, Papathanasopoulos P.
    Neurology; 2009 Jan 06; 72(1):100-1; author reply 101. PubMed ID: 19122042
    [No Abstract] [Full Text] [Related]

  • 9. [MEDICAL CANNABIS].
    Naftali T.
    Harefuah; 2016 Feb 06; 155(2):79-82, 133. PubMed ID: 27215115
    [Abstract] [Full Text] [Related]

  • 10. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
    Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T.
    Complement Ther Med; 2017 Aug 06; 33():99-104. PubMed ID: 28735833
    [Abstract] [Full Text] [Related]

  • 11. A systematic review of the effects of cannabis on cognition in people with multiple sclerosis.
    Landrigan J, Bessenyei K, Leitner D, Yakovenko I, Fisk JD, Prentice JL.
    Mult Scler Relat Disord; 2022 Jan 06; 57():103338. PubMed ID: 35158449
    [Abstract] [Full Text] [Related]

  • 12. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.
    Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A.
    Neurology; 2014 May 27; 82(21):1879-87. PubMed ID: 24789863
    [Abstract] [Full Text] [Related]

  • 13. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S, Hämäläinen P, Vorobyev V, Ruutiainen J, Parkkola R, Laine T, Hämäläinen H.
    Mult Scler; 2011 Nov 27; 17(11):1351-61. PubMed ID: 21846692
    [Abstract] [Full Text] [Related]

  • 14. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S, Søndergaard HB, Andresen SR, Magyari M, Sørensen PS, Sellebjerg F, Oturai AB.
    Mult Scler Relat Disord; 2019 Aug 27; 33():5-12. PubMed ID: 31129415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
    Cader S, Palace J, Matthews PM.
    J Psychopharmacol; 2009 Aug 27; 23(6):686-96. PubMed ID: 18635705
    [Abstract] [Full Text] [Related]

  • 17. The perceived effects of smoked cannabis on patients with multiple sclerosis.
    Consroe P, Musty R, Rein J, Tillery W, Pertwee R.
    Eur Neurol; 1997 Aug 27; 38(1):44-8. PubMed ID: 9252798
    [Abstract] [Full Text] [Related]

  • 18. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M.
    Clin Neuropharmacol; 2009 Aug 27; 32(1):41-7. PubMed ID: 18978501
    [Abstract] [Full Text] [Related]

  • 19. Distinct mechanisms of altered brain activation in patients with multiple sclerosis.
    Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D.
    Neuroimage; 2007 Sep 01; 37(3):937-46. PubMed ID: 17627848
    [Abstract] [Full Text] [Related]

  • 20. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
    Trebst C, Stangel M.
    Fortschr Neurol Psychiatr; 2005 Aug 01; 73(8):463-9. PubMed ID: 16052440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.